Suven Life Sciences Ltd. News and Updates

Name: Latest research reports of Suven Life Sciences Ltd. authored by Emkay and published by - Trendlyne research reports.
Item: Suven Life Sciences Ltd.
Rating: 5
Author: Emkay

Keep track of all breaking news on Suven Life Sciences Ltd. from all sources in a single place.

Load latest

Suven Life Sciences Ltd.

04 Jul 2018

221.85

-4.93%

Suven Life gets product patents from India, Singapore, South Korea, Israel

Business Standard

These patents are valid through 2031, 2034, 2034 and 2036 respectively, the company said in a BSE filing

Suven Life Sciences Ltd. is trading below its 30 day SMA of 239.4

Suven Life gets product patent for neurodegenerative disorders

Business Line | 04 Jul 2018

Suven Life Sciences Ltd.

12 Jun 2018

221.85

-4.93%

Suven Life gets product patents from China, US

Business Line

Suven Life Sciences today said it has been granted a product patent by China and the US each for a new chemical entity (NCE) for treatment of disord

Suven Life Sciences Ltd. has gained 43.85% in the last 1 Year

Suven Life Sciences Ltd.

08 Jun 2018

221.85

-4.93%

Suven Life Sciences (SVLS) is a compelling play on the recovery being witnessed in global...

Buy: Suven Life Sciences Ltd.

Emkay

Suven Life Sciences (SVLS) is a compelling play on the recovery being witnessed in global R&D; spending, as reflected in strong fund raising by biotech start-ups as well as a fastgrowing research pipeline across multiple stages of clinical trials. Also, the global Clinical Development & Manufacturing Organizations (CDMO) industry has undergone significant consolidation, both at the Clinical Research Organizations (CRO) level as well as at the API manufacturing level. As a result, fewer and only niche players are left in both clinical services and API manufacturing. SVLS enjoys a strong margin profile with EBITDA margin of 30%+. Earnings CAGR over FY18-20E is estimated at 19% and ROIC of 28%. We initiate coverage on SVLS with a...

Suven Life Sciences Ltd. is trading above its 200 day SMA of 175.5

Suven Life Sciences Ltd.

29 May 2018

221.85

-4.93%

Suven Life gets product patents from New Zealand, US

Business Line

Suven Life Sciences today said it has been granted a product patent by New Zealand and the US, each corresponding to a new chemical entity (NCE) for

Suven Life Sciences Ltd. has gained 43.85% in the last 1 Year

Suven Life Sciences Ltd.

22 May 2018

221.85

-4.93%

Suven Life gets product patents from New Zealand, Norway

Business Line

Suven Life Sciences on Tuesday said that it has been granted one product patent each from New Zealand and Norway corresponding to the new chemical ent

Suven Life Sciences Ltd.'s price crossed below 100Day SMA today

Suven Life gets product patents from New Zealand, Norway

livemint | 22 May 2018

Suven Life Sciences Ltd.

17 May 2018

221.85

-4.93%

Suven gets product patents for neurodegenerative disorders

Business Line

Suven Life Sciences has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity (NCE) for the treatm